11 – 20 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
- Contribution to journal › Article
-
Mark
Dietary Patterns in Prostate Cancer Prevention and Management : A Systematic Review of Prospective Cohort Studies and Randomized Clinical Trials
(2025) In European Urology
- Contribution to journal › Scientific review
-
Mark
MicroRNA-379 Modulates Prostate-Specific Antigen Expression Through Targeting the Androgen Receptor in Prostate Cancer
- Contribution to journal › Article
-
Mark
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) : Results from an International Multicentre Registry Study
(2025) In European Urology
- Contribution to journal › Article
-
Mark
Prostate cancer diagnostics: evolution over 30 years and the impact of education level – a prospective population-based study
- Contribution to journal › Article
-
Mark
Adverse events during radical prostatectomy and their association with recurrence and death
- Contribution to journal › Article
-
Mark
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy
- Contribution to journal › Article
-
Mark
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
(2025) In European Urology Focus
- Contribution to journal › Article
-
Mark
SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
(2025) In European Urology
- Contribution to journal › Article
- 2024
-
Mark
A pilot study of an organised population‐based testing programme for prostate cancer
- Contribution to journal › Article
